Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Revenue

Square Pharmaceuticals PLC. had revenue of 21.59B BDT in the quarter ending September 30, 2025, with 35.82% growth. This brings the company's revenue in the last twelve months to 75.86B, up 17.34% year-over-year. In the fiscal year ending June 30, 2024, Square Pharmaceuticals PLC. had annual revenue of 70.10B with 15.47% growth.

• Revenue (ttm): 75.86B
• Revenue Growth: +17.34%
• P/S Ratio: 2.36
• Revenue / Employee: 6.09M
• Employees: 12,453
• Market Cap: 179.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	70.10B	9.39B	15.47%
Jun 30, 2023	60.71B	3.11B	5.40%
Jun 30, 2022	57.60B	6.89B	13.60%
Jun 30, 2021	50.70B	4.83B	10.52%
Jun 30, 2020	45.88B	1.84B	4.19%